Handelsbanken Fonder’s Jazz Pharmaceuticals JAZZ Stock Holding History

Handelsbanken Fonder’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,657	Closed	-$4.49M	–	1582
2022 Q3	$4.49M	Sell	33,657 -774	-2%	-$118K	0.03%	429
2022 Q2	$5.37M	Sell	34,431 -20,479	-37%	-$3.15M	0.03%	416
2022 Q1	$8.55M	Sell	54,910 -2,931	-5%	-$425K	0.05%	353
2021 Q4	$7.37M	Buy	57,841 +6,437	+13%	+$846K	0.04%	409
2021 Q3	$6.69M	Buy	51,404 +2,752	+6%	+$416K	0.04%	421
2021 Q2	$8.64M	Buy	48,652 +33,807	+228%	+$5.86M	0.05%	373
2021 Q1	$2.44M	Buy	14,845 +315	+2%	+$51.8K	0.01%	574
2020 Q4	$2.4M	Buy	14,530 +549	+4%	+$81.8K	0.01%	572
2020 Q3	$1.99M	Hold	13,981	–	–	0.01%	564
2020 Q2	$1.54M	Buy	+13,981	New	+$1.55M	0.01%	584

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Handelsbanken Fonder's JAZZ Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2022, closing a stake of 33,657 shares — an estimated $4.49M sold.

Handelsbanken Fonder first reported a position in JAZZ in Q2 2020 and held it in 10 quarters. The position peaked at $8.64M in Q2 2021. 486 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

Handelsbanken Fonder reported no remaining Jazz Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Handelsbanken Fonder sold 33,657 Jazz Pharmaceuticals shares in Q4 2022, an estimated $4.49M.
Handelsbanken Fonder first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 10 quarters.
Handelsbanken Fonder's Jazz Pharmaceuticals position peaked at $8.64M in Q2 2021.
486 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.